Myeloma Minimal Residual Disease and Surrogacy-Reply
JAMA Oncol
.
2017 Aug 1;3(8):1136-1137.
doi: 10.1001/jamaoncol.2017.0404.
Authors
Nikhil Munshi
1
,
Mehmet Kemal Samur
1
,
Walter Gregory
2
Affiliations
1
Dana-Farber Cancer Institute, Boston, Massachusetts.
2
Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, England.
PMID:
28494053
DOI:
10.1001/jamaoncol.2017.0404
No abstract available
Publication types
Comment
MeSH terms
Humans
Multiple Myeloma*
Neoplasm, Residual
Grants and funding
G0100132/MRC_/Medical Research Council/United Kingdom